ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,084 | -26.6% | 80,169 | -19.3% | 0.01% | -28.6% |
| Q1 2024 | $2,841 | -9.9% | 99,343 | -3.6% | 0.01% | -17.6% |
| Q4 2023 | $3,152 | +7.9% | 103,014 | -5.2% | 0.02% | -5.6% |
| Q3 2023 | $2,921 | -27.5% | 108,717 | -3.8% | 0.02% | -28.0% |
| Q2 2023 | $4,029 | +83.6% | 112,972 | +30.8% | 0.02% | +66.7% |
| Q1 2023 | $2,194 | -40.2% | 86,397 | -4.5% | 0.02% | -44.4% |
| Q4 2022 | $3,667 | -99.9% | 90,421 | -16.4% | 0.03% | -3.6% |
| Q3 2022 | $3,575,000 | -9.6% | 108,180 | -3.7% | 0.03% | -9.7% |
| Q2 2022 | $3,955,000 | -33.1% | 112,320 | -12.7% | 0.03% | -26.2% |
| Q1 2022 | $5,915,000 | -40.1% | 128,618 | -13.6% | 0.04% | -40.0% |
| Q4 2021 | $9,875,000 | +45.1% | 148,942 | +81.2% | 0.07% | +29.6% |
| Q2 2021 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q1 2021 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q4 2020 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q3 2020 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q2 2020 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q1 2020 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q4 2019 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q3 2019 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q2 2019 | $6,807,000 | 0.0% | 82,196 | 0.0% | 0.05% | 0.0% |
| Q1 2019 | $6,807,000 | +680600.0% | 82,196 | +136893.3% | 0.05% | – |
| Q4 2018 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 60 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 60 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |